Carrie Ambler is a professor in the Biosciences Department at Durham University and also Chief Scientific Officer of a spinout company, LightOx. Her work directly impacted the synthesis and biological testing of new fluorescent chemicals for use as life sciences tools. These are now commercially available worldwide through Merck and are being developed to produce light-activated therapeutics for oral cancer treatments.